CD4 and neoplasm: Tretinoin is also a powerful regulator of Treg activity and can induce Foxp3 expression in peripheral CD4+ T cells, converting them to Tregs as well as increase the number of tumour infiltrating Tregs (12, 44), although we saw no changes to CD4+ Treg and non-Treg populations.